List of Testosterone Cypionate drug patents

Testosterone Cypionate is owned by Slayback Pharma Llc.

Testosterone Cypionate contains Testosterone Cypionate.

Testosterone Cypionate has a total of 1 drug patent out of which 0 drug patents have expired.

Testosterone Cypionate was authorised for market use on 02 June, 2022.

Testosterone Cypionate is available in solution;intramuscular dosage forms.

The generics of Testosterone Cypionate are possible to be released after 25 March, 2039.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11311554 SLAYBACK PHARMA LLC Pharmaceutical compositions of testosterone
Mar, 2039

(16 years from now)

Drugs and Companies using TESTOSTERONE CYPIONATE ingredient

Market Authorisation Date: 02 June, 2022

Treatment: NA

Dosage: SOLUTION;INTRAMUSCULAR

More Information on Dosage

TESTOSTERONE CYPIONATE family patents

2

United States

1

India

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in